Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

23
Yancoal to dual list onto Hong Kong exchange

2018-07-02 theage.com.au
Coal miner Yancoal will list on the Hong Kong exchange before the end of 2018 to open its books beyond five shareholders and see movement in its share price.
YZC RTPPF K3GD RIO NOBGF RIO 1171 YZCHF N21 RIO NOBGY RTNTF

23
Yancoal to dual list onto Hong Kong exchange

2018-07-02 smh.com.au
Coal miner Yancoal will list on the Hong Kong exchange before the end of 2018 to open its books beyond five shareholders and see movement in its share price.
YZC RTPPF K3GD RIO NOBGF RIO 1171 YZCHF N21 RIO NOBGY RTNTF

135
The Zacks Analyst Blog Highlights: Autohome, Kingdee International Software Group, 58.com and Yanzhou Coal Mining

2018-04-17 zacks
Chicago, IL – April 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Autohome Inc. (ATHM - Free Report) , Kingdee International Software Group Company Limited (KGDEY - Free Report) , 58.com Inc. (WUBA - Free Report) and Yanzhou Coal Mining Company Ltd.
SGC K3GD STLD 1171 YZCHF APO.PRB APO.PRA WUBA ATB BAX MCHP APO NEE.PRI NEE.PRJ 0268 YZC ATHM AMCX NEE.PRC AMAT NEE.PRQ NEE.PRR FSLR NEE

14
4 Stocks to Buy as Chinese Economy Remains Resilient

2018-04-16 zacks
The world’s second-largest economy China has been growing by leaps and bounds for the past one year. Further, the Asian Development Bank stated in a report on Apr 11 that China would keep growing more than 6% in 2018 as well as 2019. The recent shift of focus from manufacturing to services has been pivotal in China’s economic growth story.
YZC 0268 K3GD 1171 YZCHF ATHM WUBA ATB UNF

15
The Zacks Analyst Blog Highlights: Autohome, Kingdee International Software Group, China Petroleum & Chemical, Yanzhou Coal Mining and PetroChina

2018-04-06 zacks
Chicago, IL – April 6, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Autohome Inc. (ATHM - Free Report) , Kingdee International Software Group Company Ltd. (KGDEY - Free Report) , China Petroleum & Chemical Corp.
LINDW K3GD STLD 1171 YZCHF SNP LHCG LCII CLAC ZBRA LSTR YZC 0268 CVGW SNP ATHM PATK CLACW CLACU SAIC FG LIND

14
China Manufacturing & Services PMI Improve: 5 Great Choices

2018-04-05 zacks
Even as China and the United States gear up for a trade war, China’s economy has been gaining traction. While factory activity touched its highest level since last December, services activity rebounded in March after hitting a four-month low in the prior month. Increase in steel production and removal of winter pollution restrictions contributed to these gains.
YZC 0268 SNP K3GD 1171 YZCHF ATHM SNP VIRT

50
Rio Exits Coal Business With $4 Billion of Deals in a Week - Bloomberg

2018-03-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
K3GD RIO BLT RIO 1171 YZCHF BHPBF AAL YZC RTPPF BHP UBS AAUKF RIO RTNTF BBL UBS.PRDCL BHP BHPLF NGLOY ULSGF

0
Shenhua Profit Rises to 5-Year High as China Curbs Boost Coal - Bloomberg

2018-03-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
1898 YACAF YZC K3GD 1171 YZCHF YAL 1088

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...